Lam Research (LRCX) director Eric Brandt sells 35,000 shares in two trades

Rhea-AI Filing Summary

Lam Research Corporation director Eric Brandt reported selling common stock in two transactions. On February 6, 2026, he sold 17,000 shares at $220.95 per share and 18,000 shares at $230 per share.

After these sales, Brandt beneficially owned 253,705 shares of Lam Research common stock directly. This reported amount includes shares that are subject to unvested restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRANDT ERIC

(Last) (First) (Middle)

C/O LAM RESEARCH CORPORATION

4650 CUSHING PARKWAY

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		S		17,000	D	$220.95	271,705(1)	D
Common Stock	02/06/2026		S		18,000	D	$230	253,705(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	Marta Woods by Power of Attorney	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lam Research (LRCX) director Eric Brandt report?

Eric Brandt reported selling Lam Research common stock in two separate transactions. He sold 17,000 shares at $220.95 and 18,000 shares at $230.00, both on February 6, 2026, as disclosed in the Form 4 filing.

How many Lam Research (LRCX) shares did Eric Brandt sell and at what prices?

Eric Brandt sold a total of 35,000 Lam Research common shares. He sold 17,000 shares at $220.95 per share and 18,000 shares at $230.00 per share on February 6, 2026, according to the insider transaction report.

How many Lam Research (LRCX) shares does Eric Brandt own after the reported sale?

After the reported transactions, Eric Brandt beneficially owns 253,705 shares of Lam Research common stock. This total is reported as directly held and includes shares subject to unvested restricted stock units, as noted in the filing footnote.

What is Eric Brandt’s role at Lam Research (LRCX) in this insider filing?

In this insider filing, Eric Brandt is identified as a director of Lam Research Corporation. He is not listed as a 10% owner or officer, and the Form 4 is filed as a single reporting person transaction under Section 16 rules.

Does Eric Brandt hold Lam Research (LRCX) stock directly or indirectly?

The Form 4 shows Eric Brandt’s Lam Research holdings as directly owned. The 253,705 beneficially owned shares are marked with ownership form “D” for direct, and the footnote clarifies that this amount includes unvested restricted stock units.

What does the footnote about Lam Research (LRCX) restricted stock units indicate?

The footnote explains that the reported beneficial ownership for Eric Brandt includes shares subject to unvested restricted stock units. This means his 253,705-share figure combines currently held shares and shares tied to outstanding equity awards that have not yet fully vested.